Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and Northern blot analysis

The multidrug resistance (MDR) phenotype has been demonstrated to be related to the overexpression of P-glycoprotein, a 170 kDa transmembrane efflux pump. We studied P-glycoprotein expression in 40 patients with chronic B-cell leukemias by FACS analysis using MoAb c219, which recognizes both the MDR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wulf, Gerburg (VerfasserIn) , Kluding-Münch, Hildegard (VerfasserIn) , Ho, Anthony Dick (VerfasserIn) , Dörner, Maria (VerfasserIn) , Döhner, Hartmut (VerfasserIn) , Manegold, Christian (VerfasserIn) , Hunstein, Werner (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: July 1994
In: Leukemia research
Year: 1994, Jahrgang: 18, Heft: 7, Pages: 475-484
ISSN:1873-5835
DOI:10.1016/0145-2126(94)90085-X
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/0145-2126(94)90085-X
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/014521269490085X
Volltext
Verfasserangaben:Gerburg Wulf, Hildegard Kluding, Anthony D.Ho, Maria Doerner, Hartmut Doehner, Christoph Manegold, und Werner Hunstein

MARC

LEADER 00000naa a2200000 c 4500
001 1941609422
003 DE-627
005 20251119142037.0
007 cr uuu---uuuuu
008 251119s1994 xx |||||o 00| ||eng c
024 7 |a 10.1016/0145-2126(94)90085-X  |2 doi 
035 |a (DE-627)1941609422 
035 |a (DE-599)KXP1941609422 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wulf, Gerburg  |e VerfasserIn  |0 (DE-588)1382002262  |0 (DE-627)1941610161  |4 aut 
245 1 0 |a Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and Northern blot analysis  |c Gerburg Wulf, Hildegard Kluding, Anthony D.Ho, Maria Doerner, Hartmut Doehner, Christoph Manegold, und Werner Hunstein 
264 1 |c July 1994 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Elektronische Reproduktion der Druck-Ausgabe 22. April 2004 
500 |a Gesehen am 19.11.2025 
520 |a The multidrug resistance (MDR) phenotype has been demonstrated to be related to the overexpression of P-glycoprotein, a 170 kDa transmembrane efflux pump. We studied P-glycoprotein expression in 40 patients with chronic B-cell leukemias by FACS analysis using MoAb c219, which recognizes both the MDR1 and the MDR3 gene product. We found significantly elevated P-glycoprotein expression in these patients as compared with normal controls. Patients who had received previous chemotherapy regimens containing MDR-related drugs showed significantly higher P-glycoprotein expression with MoAb c219 than those patients who had been untreated. Northern blot analysis of MDR1 and MDR3 gene expression in 32 of the patients gave a similar result: in the analysis of total RNA four of six patients (66%) pretreated with either vinea alkaloids or anthracyclines were MDR1 positive as opposed to 6 of 26 (23%) who had no treatment or treatment without these agents. In contrast, MDR3 expression was found more frequently (63%), but was randomly distributed in the differently treated groups. Increasing the sensitivity level by analysis of enriched mRNA (polyA + RNA) led to the detection of MDR1 and MDR3 expression all B-CLL patients. We conclude that a basic elevated P-glycoprotein expression is intrinsic in CLL cells, which is possibly upregulated under chemotherapy. This might be responsible for initial and acquired chemotherapy resistance in CLL patients. Follow-up of the B-CLL patients over 46 months showed that the median survival time for MDR1+ patients was 19 months as opposed to 46 months for MDR1- patients (p < 0.01). There was no statistical difference in survival between MDR3+ and MDR3- patients. In the MDR1+ group, eight of nine patients had developed resistance to the therapy with MDR-related drugs. The expression of MDR1 might, therefore, predict treatment failure with MDR-related drugs and be a negative prognostic factor. 
650 4 |a chronic lymphocytic leukemia 
650 4 |a flow cytometry 
650 4 |a MDR1 
650 4 |a MDR3 
650 4 |a Multidrug resistance 
700 1 |a Kluding-Münch, Hildegard  |e VerfasserIn  |0 (DE-588)1137197048  |0 (DE-627)894167707  |0 (DE-576)173855555  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Dörner, Maria  |e VerfasserIn  |0 (DE-588)1247318710  |0 (DE-627)1780995148  |4 aut 
700 1 |a Döhner, Hartmut  |d 1957-  |e VerfasserIn  |0 (DE-588)110666585  |0 (DE-627)729880842  |0 (DE-576)375358846  |4 aut 
700 1 |a Manegold, Christian  |d 1946-2022  |e VerfasserIn  |0 (DE-588)108614913  |0 (DE-627)490287360  |0 (DE-576)289617200  |4 aut 
700 1 |a Hunstein, Werner  |d 1928-2012  |e VerfasserIn  |0 (DE-588)1012782662  |0 (DE-627)699775833  |0 (DE-576)345935667  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia research  |d Amsterdam [u.a.] : Elsevier Science, 1977  |g 18(1994), 7, Seite 475-484  |h Online-Ressource  |w (DE-627)320467031  |w (DE-600)2008028-1  |w (DE-576)095956301  |x 1873-5835  |7 nnas  |a Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and Northern blot analysis 
773 1 8 |g volume:18  |g year:1994  |g number:7  |g pages:475-484  |g extent:10  |a Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and Northern blot analysis 
856 4 0 |u https://doi.org/10.1016/0145-2126(94)90085-X  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/014521269490085X  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20251119 
993 |a Article 
994 |a 1994 
998 |g 1012782662  |a Hunstein, Werner  |m 1012782662:Hunstein, Werner  |d 910000  |d 910100  |e 910000PH1012782662  |e 910100PH1012782662  |k 0/910000/  |k 1/910000/910100/  |p 7  |y j 
998 |g 108614913  |a Manegold, Christian  |m 108614913:Manegold, Christian  |d 910000  |d 950000  |d 950900  |e 910000PM108614913  |e 950000PM108614913  |e 950900PM108614913  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 6 
998 |g 110666585  |a Döhner, Hartmut  |m 110666585:Döhner, Hartmut  |d 910000  |d 910100  |e 910000PD110666585  |e 910100PD110666585  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1137197048  |a Kluding-Münch, Hildegard  |m 1137197048:Kluding-Münch, Hildegard  |d 50000  |e 50000PK1137197048  |k 0/50000/  |p 2 
999 |a KXP-PPN1941609422  |e 4808692511 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and Northern blot analysis","title_sort":"Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and Northern blot analysis"}],"language":["eng"],"name":{"displayForm":["Gerburg Wulf, Hildegard Kluding, Anthony D.Ho, Maria Doerner, Hartmut Doehner, Christoph Manegold, und Werner Hunstein"]},"person":[{"family":"Wulf","display":"Wulf, Gerburg","given":"Gerburg","role":"aut"},{"family":"Kluding-Münch","role":"aut","given":"Hildegard","display":"Kluding-Münch, Hildegard"},{"family":"Ho","role":"aut","given":"Anthony Dick","display":"Ho, Anthony Dick"},{"family":"Dörner","role":"aut","given":"Maria","display":"Dörner, Maria"},{"display":"Döhner, Hartmut","given":"Hartmut","role":"aut","family":"Döhner"},{"role":"aut","given":"Christian","display":"Manegold, Christian","family":"Manegold"},{"given":"Werner","role":"aut","display":"Hunstein, Werner","family":"Hunstein"}],"origin":[{"dateIssuedDisp":"July 1994","dateIssuedKey":"1994"}],"recId":"1941609422","type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1016/0145-2126(94)90085-X"],"eki":["1941609422"]},"physDesc":[{"extent":"10 S."}],"note":["Elektronische Reproduktion der Druck-Ausgabe 22. April 2004","Gesehen am 19.11.2025"],"relHost":[{"title":[{"subtitle":"clinical and laboratory studies","title":"Leukemia research","title_sort":"Leukemia research"}],"language":["eng"],"part":{"extent":"10","pages":"475-484","issue":"7","volume":"18","year":"1994","text":"18(1994), 7, Seite 475-484"},"pubHistory":["1.1977 -"],"disp":"Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and Northern blot analysisLeukemia research","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["320467031"],"zdb":["2008028-1"],"issn":["1873-5835"]},"note":["Gesehen am 16.01.20","Ungezählte Beil.: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"320467031","origin":[{"publisher":"Elsevier Science","dateIssuedDisp":"1977-","dateIssuedKey":"1977","publisherPlace":"Amsterdam [u.a.]"}]}]} 
SRT |a WULFGERBURMULTIDRUGR1994